Jacinth Fairley
Director/Board Member chez MIRRABOOKA INVESTMENTS LIMITED
Fortune : 425 311 $ au 31/03/2024
Profil
Jacinth K.
Fairley is an Independent Non-Executive Director at Mirrabooka Investments Ltd.
She was previously the Chief Executive Officer, MD & Executive Director at Starpharma Holdings Ltd.
from 2006 to 2024.
She was also the Director at Melbourne Business School from 2010 to 2020.
Additionally, she is a Member of the Pharmaceutical Industry Working Group.
Fairley holds an MBA from Melbourne Business School and an undergraduate degree from the University of Melbourne.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/10/2023 | 4 055 434 ( 0,98% ) | 330 721 $ | 31/03/2024 | |
| 19/02/2024 | 43 540 ( 0,02% ) | 94 590 $ | 31/03/2024 |
Postes actifs de Jacinth Fairley
| Sociétés | Poste | Début |
|---|---|---|
| MIRRABOOKA INVESTMENTS LIMITED | Director/Board Member | 15/02/2018 |
Anciens postes connus de Jacinth Fairley
| Sociétés | Poste | Fin |
|---|---|---|
| STARPHARMA HOLDINGS LIMITED | Chief Executive Officer | 08/01/2024 |
| Melbourne Business School | Director/Board Member | 01/12/2020 |
| Pharmaceutical Industry Working Group | Corporate Officer/Principal | - |
Formation de Jacinth Fairley
| Melbourne Business School | Masters Business Admin |
| University of Melbourne | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| STARPHARMA HOLDINGS LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Mirrabooka Investments Ltd.
 Mirrabooka Investments Ltd. Investment Trusts/Mutual FundsMiscellaneous Mirrabooka Investments Ltd. is closed-end investment fund/Investment trust. It invests in small and medium sized companies located in Australia and New Zealand. The company was founded in December 1998 and is headquartered in Melbourne, Australia. | Miscellaneous |
| Pharmaceutical Industry Working Group |
